Folgen
Mario Masarone
Mario Masarone
Internal Medicine and Hepatology Unit, Salerno University
Bestätigte E-Mail-Adresse bei unisa.it
Titel
Zitiert von
Zitiert von
Jahr
Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease
M Masarone, V Rosato, M Dallio, AG Gravina, A Aglitti, C Loguercio, ...
Oxidative medicine and cellular longevity 2018, 2018
5982018
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis
B Palmentieri, I De Sio, V La Mura, M Masarone, R Vecchione, S Bruno, ...
Digestive and Liver Disease 38 (7), 485-489, 2006
4182006
Non alcoholic fatty liver: epidemiology and natural history
M Masarone, A Federico, L Abenavoli, C Loguercio, M Persico
Reviews on recent clinical trials 9 (3), 126-133, 2014
3402014
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea
AG Gravina, A Federico, E Ruocco, AL Schiavo, M Masarone, C Tuccillo, ...
United European gastroenterology journal 3 (1), 17-24, 2015
1342015
NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome
V Rosato, M Masarone, M Dallio, A Federico, A Aglitti, M Persico
International journal of environmental research and public health 16 (18), 3415, 2019
1302019
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
M Masarone, V Rosato, A Aglitti, T Bucci, R Caruso, T Salvatore, ...
PLoS one 12 (6), e0178473, 2017
1062017
Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study
G Guiotto, M Masarone, F Paladino, E Ruggiero, S Scott, S Verde, ...
Intensive care medicine 36, 692-696, 2010
942010
Efficacy and safety of new direct antiviral agents in hepatitis C virus–infected patients with diffuse large B‐cell non‐Hodgkin's lymphoma
M Persico, A Aglitti, R Caruso, A De Renzo, C Selleri, C Califano, ...
Hepatology 67 (1), 48-55, 2018
892018
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
L Abenavoli, M Masarone, V Peta, N Milic, N Kobyliak, S Rouabhia, ...
World journal of gastroenterology: WJG 20 (41), 15233, 2014
892014
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma
V La Mura, A De Renzo, F Perna, D D’Agostino, M Masarone, M Romano, ...
Journal of hepatology 49 (4), 557-563, 2008
872008
The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction.
A Federico, M Dallio, M Masarone, M Persico, C Loguercio
European Review for Medical & Pharmacological Sciences 20 (22), 2016
842016
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years
M Persico, S Perrotta, E Persico, L Terracciano, A Folgori, L Ruggeri, ...
Journal of viral hepatitis 13 (5), 290-296, 2006
782006
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease
A Federico, C Zulli, I De Sio, A Del Prete, M Dallio, M Masarone, ...
World Journal of Gastroenterology: WJG 20 (45), 16841, 2014
772014
Lung ultrasound for diagnosis of pneumonia in emergency department
A Pagano, FG Numis, G Visone, C Pirozzi, M Masarone, M Olibet, R Nasti, ...
Internal and emergency medicine 10, 851-854, 2015
762015
Epidemiology and natural history of alcoholic liver disease
M Masarone, V Rosato, M Dallio, L Abenavoli, A Federico, C Loguercio, ...
Reviews on recent clinical trials 11 (3), 167-174, 2016
702016
Interleukin-10− 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection
M Persico, M Capasso, E Persico, M Masarone, A De Renzo, D Spano, ...
Journal of hepatology 45 (6), 779-785, 2006
692006
The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials
C Izzo, M Annunziata, G Melara, R Sciorio, M Dallio, M Masarone, ...
Nutrients 13 (3), 933, 2021
682021
Non alcoholic fatty liver disease and eNOS dysfunction in humans
M Persico, M Masarone, A Damato, M Ambrosio, A Federico, V Rosato, ...
BMC gastroenterology 17, 1-9, 2017
652017
Evaluation of the effect derived from silybin with vitamin D and vitamin E administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and …
A Federico, M Dallio, M Masarone, AG Gravina, R Di Sarno, C Tuccillo, ...
Oxidative Medicine and Cellular Longevity 2019, 2019
612019
Role of bisphenol A as environmental factor in the promotion of non‐alcoholic fatty liver disease: in vitro and clinical study
M Dallio, M Masarone, S Errico, AG Gravina, C Nicolucci, R Di Sarno, ...
Alimentary pharmacology & therapeutics 47 (6), 826-837, 2018
612018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20